Clinical Practice of Targeted Capture Sequencing to Identify Actionable Alterations in Cholangiocarcinoma
The early diagnosis and treatment of cholangiocarcinoma (CCA) remain a challenge worldwide. Genetic testing promises to solve these problems. Due to the different mutation landscapes across populations and the paucity of sequencing data of Chinese patients with CCA, the existing mutation landscape i...
Main Authors: | Kai Ma, Youpeng Wang, Yuanzheng Zhang, Hongfa Sun, Xuhui Zhang, Chuandong Sun, Bingyuan Zhang, Ying Zhang, Haoyue Cheng, Ao Liu, Mengyao Wang, Bing Han |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/20/5062 |
Similar Items
-
Are FGFR and IDH1-2 alterations a positive prognostic factor in intrahepatic cholangiocarcinoma? An unresolved issue
by: Giovanni Brandi, et al.
Published: (2023-04-01) -
Benchmarking Outcomes after Ablative Radiotherapy for Molecularly Characterized Intrahepatic Cholangiocarcinoma
by: Brian De, et al.
Published: (2021-12-01) -
Omics-Based Platforms: Current Status and Potential Use for Cholangiocarcinoma
by: Yu-Chan Chang, et al.
Published: (2020-09-01) -
Isocitrate dehydrogenase 1 mutation in cholangiocarcinoma impairs tumor progression by sensitizing cells to ferroptosis
by: Su Li, et al.
Published: (2022-05-01) -
Locoregional Treatments in Cholangiocarcinoma and Combined Hepatocellular Cholangiocarcinoma
by: Matteo Renzulli, et al.
Published: (2021-07-01)